The Latest in Dermatology

Internal Medicine News

Aspects of the Skin Microbiome Remain Elusive

September 30, 2024

Dermatology

Internal Medicine News

Childhood-Onset Atopic Dermatitis Adds Burden in Adulthood

September 27, 2024

Internal Medicine News

Phase3 Data: Atopic Dermatitis Symptoms Improved with Topical Roflumilast

September 26, 2024

Dermatology

Internal Medicine News

A 71-year-old White female developed erosions after hip replacement surgery 2 months prior to presentation

September 24, 2024

Dermatology

Internal Medicine News

Bimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial Spondyloarthritis

September 24, 2024

Internal Medicine News

New Options for Treating Atopic Dermatitis Available, and in Development

September 23, 2024

Dermatology

Internal Medicine News

Seborrheic Dermatitis in Black Patients: New Therapies Offer Hope

September 23, 2024

Internal Medicine News

Melanoma: Neoadjuvant Immunotherapy Provides Optimal Survival Results

September 23, 2024

Internal Medicine News

Identifying Drug-Induced Rashes in Skin of Color: Heightened Awareness Can Accelerate Diagnosis

September 23, 2024

Internal Medicine News

Expert Warns of Problems with Large Language Models in Dermatology

September 18, 2024

Internal Medicine News

Diabetes Drug Improved Symptoms in Small Study of Women With Central Centrifugal Cicatricial Alopecia

September 18, 2024

Internal Medicine News

Study Helps Define Patient-Centered Definition of Atopic Dermatitis Flares

September 18, 2024

Dermatology

Internal Medicine News

Imaging Tool Helps Identify Features of Nail Disorders

September 18, 2024

Internal Medicine News

FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer Indications

September 17, 2024

Internal Medicine News

FDA Approves IL-13 inhibitor for Atopic Dermatitis

September 16, 2024